Journal Mobile Options
Table of Contents
Vol. 10, No. 6, 2002/2003
Issue release date: August 2003
Neuroimmunomodulation 2002–03;10:337–343

Coemergence of Insomnia and a Shift in the Th1/Th2 Balance toward Th2 Dominance

Sakami S. · Ishikawa T. · Kawakami N. · Haratani T. · Fukui A. · Kobayashi F. · Fujita O. · Araki S. · Kawamura N.
aDivision of Psychosomatic Research, National Institute of Mental Health, Chiba, bDepartment of Public Health, University of Tokyo, Tokyo, cOkayama University Graduate School of Medicine and Dentistry, dNational Institute of Industrial Health, Kanagawa, eDepartment of Internal Medicine, University of Nagoya, Nagoya, fDepartment of Psychosocial Medicine, Aichi Medical University, gHealth Care Center, Aichi University of Education, Aichi, Japan

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Objectives: Insomnia is associated with physical and mental disorders. We examined the effect of insomnia on immune functions, focusing on the T helper 1 (Th1)/ T helper 2 (Th2) balance, by a cross-sectional design. Methods: We provided a self-administered questionnaire to evaluate sleep habits, smoking and medical disorders to 578 men without any toxic exposure (20–64 years old), and measured natural killer (NK) cell activity in 324 men and production of interferon-gamma (IFN-γ) and interleukin-4 (IL-4) after stimulation with phytohemagglutinin in 254 men. According to the criteria of DSM-IV, in which insomnia is classified into primary and secondary insomnia, we assessed the effect of insomnia on immune functions, controlling for age and smoking in groups with and without medical disorders. Results: The prevalence of insomnia in the present study was 9.2%. In the absence of medical disorders, insomniac men had a significantly lower IFN-γ and ratio of IFN-γ to IL-4 than noninsomniac men. Men with insufficient sleep or difficulty initiating sleep (DIS) had a significantly lower IFN-γ to IL-4 ratio than those not suffering from insufficient sleep or DIS. In the presence of medical disorders, insomniac men had significantly higher IL-4 than noninsomniac men. Men with difficulty maintaining sleep (DMS) had a significantly lower IFN-γ to IL-4 ratio than men without DMS. NK cell activity was independent of insomnia. Conclusions: The present results showed a link between insomnia unrelated to medical disorders and a shift in the Th1/Th2 balance toward Th2 dominance, indicating that the relationship between sleep quality and the etiology of immune-related diseases should be reconsidered.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Born J, Lange T, Hansen K, Molle M, Fehm HL: Effects of sleep and circadian rhythm on human circulating immune cells. J Immunol 1997;158:4454–4464.
  2. Irwin M, McClintick J, Costlow C, Fortner M, White J, Gillin JC: Partial night sleep deprivation reduces natural killer and cellular immune responses in humans. FASEB J 1996;10:643–653.
  3. Dinges DF, Douglas SD, Zaugg L, Campbell DE, McMann JM, Whitehouse WG, Orne EC, Kapoor SC, Icaza E, Orne MT: Leukocytosis and natural killer cell function parallel neurobehavioral fatigue induced by 64 h of sleep deprivation. J Clin Invest 1994;93:1930–1939.
  4. Shearer WT, Reuben JM, Mullington JM, Price NJ, Lee BN, Smith EO, Szuba MP, Van Dongen HP, Dinges DF: Soluble TNF-alpha receptor 1 and IL-6 plasma levels in humans subjected to the sleep deprivation model of spaceflight. J Allergy Clin Immunol 2001;107:165–170.
  5. Leonard BE: The immune system, depression and the action of antidepressants. Prog Neuropsychopharmacol Biol Psychiatry 2001;25:767–780.

    External Resources

  6. van Keimpema AR, Ariaansz M, Nauta JJ, Postmus PE: Subjective sleep quality and mental fitness in asthmatic patients. J Asthma 1995;32:69–74.
  7. Darko DF, Mitler MM, Henriksen SJ: Lentiviral infection, immune response peptides and sleep. Adv Neuroimmunol 1995;5:57–77.
  8. Everson CA, Toth LA: Systemic bacterial invasion induced by sleep deprivation. Am J Physiol Regul Integr Comp Physiol 2000;278:R905–R916.
  9. Pollmacher T, Schuld A, Kraus T, Haack M, Hinze-Selch D, Mullington J: Experimental immunomodulation, sleep, and sleepiness in humans. Ann NY Acad Sci 2000;917:488–499.
  10. Ancoli-Israel S, Roth T: Characteristics of insomnia in the United States: Results of the National Sleep Foundation Survey. I. Sleep 1999;22(suppl 2):S347–S353.
  11. Janson C, Lindberg E, Gislason T, Elmasry A, Boman G: Insomnia in men – a 10-year prospective population based study. Sleep 2001;24:425–430.
  12. Stooler MK: The socio-economics of insomnia: The materials and methods. Eur Psychiatry 1997;12:41–48.

    External Resources

  13. Leger D, Scheuermaier K, Phillip P, Paillard M, Guilleminault C: SF-36: Evaluation of quality of life in severe and mild insomniacs compared with good sleepers. Psychosom Med 2001;63:49–55.
  14. Imai K, Matsuyama S, Miyake S, Suga K, Nakachi K: Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: An 11-year follow-up study of a general population. Lancet 2000;356:1795–1799.
  15. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4 (DSM-IV). Washington, American Psychiatric Association, 1994.
  16. Shearer GM: Th1/Th2 changes in aging. Mech Ageing Dev 1997;94:1–5.
  17. Kusaka Y, Kondou H, Morimoto K: Healthy lifestyles are associated with higher natural killer cell activity. Prev Med 1992;21:602–615.
  18. Hughes DA, Haslam PL, Towsend PJ, Turner-Warwick M: Numerical and functional alterations in circulatory lymphocytes in cigarette smokers. Clin Exp Immunol 1985;61:459–466.
  19. Byron KA, Varigos GA, Woottton AM: IL-4 production is increased in cigarette smokers. Clin Exp Immunol 1994;95:333–336.
  20. Morin CH: The nature of insomnia and the need to refine our diagnostic criteria. Psychosom Med 2000;62:483–485.
  21. Dodge R, Cline MG, Quan SF: The natural history of insomnia and its relationship to respiratory symptoms. Arch Intern Med 1995;155:1797–1800.
  22. Kim K, Uchiyama M, Liu X, Shibui K, Ohida T, Ogihara R, Okawa M: Somatic and psychological complaints and their correlates with insomnia in the Japanese general population. Psychosom Med 2001;63:441–446.
  23. Koh K, Bong MD, Bong K: Reduced lymphocyte proliferation and interleukin-2 production in anxiety disorders. Psychosom Med 1998;60:479–483.
  24. Nagatomi R, Kaifu T, Okutsu M, Zhang X, Kanemi O, Ohmori H: Modulation of the immune system by the autonomic nervous system and its implication in immunological changes after training. Exerc Immunol Rev 2000;6:54–74.
  25. Irwin M, Thompson J, Miller C, Gillin JC, Ziegler M: Effects of sleep and sleep deprivation on catecholamine and interleukin-2 levels in humans: Clinical implications. J Clin Endocrinol Metab 1999;84:1979–1985.
  26. Delgado M, Leceta J, Sun W, Gomariz RP, Ganea D: VIP and PACAP induce shift to a Th2 response by upregulating B7.2 expression. Ann NY Acad Sci 2000;921:68–78.
  27. Kawamura N, Tamura H, Obana S, Wenner M, Ishikawa T, Nakata A, Yamamoto H: Differential effects of neuropeptides on cytokine production by mouse helper T cell subsets. Neuroimmunomodulation 1998;5:9–15.
  28. Petrovsky N, Harrison LC: Diurnal rhythmicity of human cytokine production: A dynamic disequilibrium in T helper cell type 1/T helper cell type 2 balance? J Immunol 1997;158:5163–5168.
  29. Visser J, van Boxel-Dezaire A, Methorst D, Brunt T, de Kloet ER, Nagelkerken L: Differential regulation of interleukin-10 (IL-10) and IL-12 by glucocorticoids in vitro. Blood 1998;91:4255–4264.
  30. Vgontzas AN, Bixler EO, Lin HM, Prolo P, Mastorakos G, Vela-Bueno A, Kales A, Chrousos GP: Chronic insomnia is associated with nyctohemeral activation of the hypothalamic-pituitary-adrenal axis: Clinical implications. J Clin Endocrinol Metab 2001;86:3787–3794.
  31. Dauvilliers Y, Neidhart E, Lecendreux M, Billiard M, Tafti M: MAO-A and COMT polymorphisms and gene effects in narcolepsy. Mol Psychiatry 2001;6:367–372.
  32. Kahn A, Rebuffat E, Blum D, Casimir G, Duchateau J, Mozin MJ, Jost R: Difficulty in initiating and maintaining sleep associated with cow’s milk allergy in infants. Sleep 1987;10:116–121.
  33. Kushikata T, Fang J, Wang Y, Krueger JM: Interleukin-4 inhibits spontaneous sleep in rabbits. Am J Physiol 1998;275:1185–1191.
  34. Wamboldt MZ, Hewitt JK, Schmitz S, Wamboldt FS, Rasanen M, Koskenvuo MR, Romanov K, Varjonen J, Kaprio J: Familial association between allergic disorders and depression in adult Finnish twins. Am J Med Genet 2000;96:146–153.
  35. Marshall PS: Allergy and depression: A neurochemical threshold model of the relation between the illnesses. Psychol Bull 1993;113:23–43.
  36. Urponen H, Vuori I, Hasan J, Partinen M: Self-evaluations of factors promoting and disturbing sleep: An epidemiological survey in Finland. Soc Sci Med 1988;26:443–450.
  37. Marshall GD Jr, Agarwal SK: Stress, immune regulation, and immunity: Applications for asthma. Allergy Asthma Proc 2000;21:241–246.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50